I've seen a lot of posts referring to upcoming trial data in November. Is this just referring to the trial-in-progress poster presentation at SITC?
If so, are we expecting much more than we already know - it's safe, well tolerated and appears to be finding and replicating in tumour cells?
And if so, can we expect much of a SP response?
Or have I missed reference to something bigger in a webinar or interview?
I've seen a lot of posts referring to upcoming trial data...
-
- There are more pages in this discussion • 8,064 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $389.5M | |||
| Open | High | Low | Value | Volume |
| 5.3¢ | 5.4¢ | 5.1¢ | $717.6K | 13.61M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 1468251 | 5.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.4¢ | 457393 | 5 |
View Market Depth
| Last trade - 16.10pm 31/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |